Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 2/2005

01-02-2005 | Concise Article

Neisseria meningitidis C:2b:P1.2,5 with decreased susceptibility to penicillin isolated from a patient with meningitis and purpura fulminans

Authors: P. Fangio, L. Desbouchages, J. C. Lachérade, B. De Jonghe, J. P. Terville, M. Leneveu, H. Outin

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2005

Login to get access

Abstract

This report describes the case of an 18-year-old woman with meningococcal meningitis and purpura fulminans. Cerebrospinal fluid culture revealed Neisseria meningitidis serogroup-serotype-serosubtype C:2b:P1.2,5 as the pathogenic organism. Following treatment with cefotaxime and management of multiple organ failure, the patient survived without sequelae. To the best of our knowledge this report represents the first case of a meningococcal strain with a minimum inhibitory concentration of 1.5 μg/ml for penicillin, without β-lactamase production, to be documented in France. The prevalence of meningococci with reduced susceptibility to penicillin is increasing. The emergence of such strains might represent a serious problem affecting the empirical antibiotic treatment of meningococcal disease.
Literature
1.
go back to reference Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM (2001) Meningococcal disease. N Engl J Med 344:1378–1388CrossRef Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM (2001) Meningococcal disease. N Engl J Med 344:1378–1388CrossRef
2.
go back to reference Antignac A, Ducos-Galand M, Guiyoule A, Pirès R, Alonso JM, Taha MK (2003) Neisseria meningitidis strains isolated from invasive infections in France (1999–2002): phenotypes and antibiotic susceptibility patterns. Clin Infect Dis 37:912–920CrossRef Antignac A, Ducos-Galand M, Guiyoule A, Pirès R, Alonso JM, Taha MK (2003) Neisseria meningitidis strains isolated from invasive infections in France (1999–2002): phenotypes and antibiotic susceptibility patterns. Clin Infect Dis 37:912–920CrossRef
3.
go back to reference Quagliarello VJ, Scheld WM (1997) Treatment of bacterial meningitis. N Engl J Med 336:708–716CrossRef Quagliarello VJ, Scheld WM (1997) Treatment of bacterial meningitis. N Engl J Med 336:708–716CrossRef
4.
go back to reference Oppenheim BA (1997) Antibiotic resistance in Neisseria meningitidis. Clin Infect Dis 24 (Suppl 1):98–101 Oppenheim BA (1997) Antibiotic resistance in Neisseria meningitidis. Clin Infect Dis 24 (Suppl 1):98–101
5.
go back to reference Spratt BG, Bowler LD, Zhang QY, Zhou J, Smith JM (1992) Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species. J Mol Evol 34:115–125CrossRef Spratt BG, Bowler LD, Zhang QY, Zhou J, Smith JM (1992) Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species. J Mol Evol 34:115–125CrossRef
6.
go back to reference Vazquez JA, Enriquez AM, De la Fuente L, Berron S, Baquero M (1996) Isolation of a strain of beta-lactamase-producing Neisseria meningitidis in Spain. Eur J Clin Microbiol Infect Dis 15:181–182 Vazquez JA, Enriquez AM, De la Fuente L, Berron S, Baquero M (1996) Isolation of a strain of beta-lactamase-producing Neisseria meningitidis in Spain. Eur J Clin Microbiol Infect Dis 15:181–182
7.
go back to reference Grzybowska W, Tyski S, Berthelsen L, Lind I (2001) Cluster analysis of Neisseria meningitidis type 22 strains isolated in Poland. Eur J Clin Microbiol Infect Dis 20:243–247CrossRef Grzybowska W, Tyski S, Berthelsen L, Lind I (2001) Cluster analysis of Neisseria meningitidis type 22 strains isolated in Poland. Eur J Clin Microbiol Infect Dis 20:243–247CrossRef
8.
go back to reference Antignac A, Boneca IG, Rousselle JC, Namane A, Carlier JP, Vazquez JA, Fox A, Alonso JM, Taha MK (2003) Correlation between alterations of penicillin-binding protein 2 and modifications of the peptidoglycan structure in Neisseria meningitidis with reduced susceptibility to penicillin G. J Biol Chem 278:31529–31535CrossRef Antignac A, Boneca IG, Rousselle JC, Namane A, Carlier JP, Vazquez JA, Fox A, Alonso JM, Taha MK (2003) Correlation between alterations of penicillin-binding protein 2 and modifications of the peptidoglycan structure in Neisseria meningitidis with reduced susceptibility to penicillin G. J Biol Chem 278:31529–31535CrossRef
9.
go back to reference Arreaza L, Salcedo C, Alcala B, Uria MJ, Abad R, Enriquez R, Vazquez JA (2004) Sequencing of Neisseria meningitidis penA gene: the key to success in defining penicillin G breakpoints. Antimicrob Agents Chemother 48:358–359CrossRef Arreaza L, Salcedo C, Alcala B, Uria MJ, Abad R, Enriquez R, Vazquez JA (2004) Sequencing of Neisseria meningitidis penA gene: the key to success in defining penicillin G breakpoints. Antimicrob Agents Chemother 48:358–359CrossRef
Metadata
Title
Neisseria meningitidis C:2b:P1.2,5 with decreased susceptibility to penicillin isolated from a patient with meningitis and purpura fulminans
Authors
P. Fangio
L. Desbouchages
J. C. Lachérade
B. De Jonghe
J. P. Terville
M. Leneveu
H. Outin
Publication date
01-02-2005
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2005
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-005-1283-0

Other articles of this Issue 2/2005

European Journal of Clinical Microbiology & Infectious Diseases 2/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.